NVS Is Delivering Strong Cash Yield, Are You Paying Attention?

NVS: Novartis logo
NVS
Novartis

Here is why we think NVS is worth a look

  • Not many stocks offer free cash flow yield of 6.2%, but NVS does
  • Last 12 month revenue growth of 11.5% and operating margin of 23.4% show good fundamentals
  • At PE of 18.5, this combo of cash yield, growth, and margin could get noticed

That is one way to look at stocks. Trefis High Quality Portfolio evaluates much more, and is designed to reduce stock-specific risk while giving upside exposure

NVS
Sector Health Care
Industry Pharmaceuticals
FCF Yield 6.2%
Revenue Growth LTM 11.5%
Revenue Growth 3YAVG 10.4%
Operating Margins LTM 29.8%
Operating Margins 3YAVG 23.4%
PE Ratio 18.5

Proof That It Works

Here are some stocks that showed strong cash flow yield in mid 2024, and saw strong returns in the subsequent 12 months

Relevant Articles
  1. The Next Big Rally in Ford Motor Stock Could Start Like This
  2. The Risk Factors to Watch Out For in NVIDIA Stock
  3. Intuitive Surgical Stock Now 16% Cheaper, Time To Buy
  4. AT&T Stock Pays Out $85 Bil – Investors Take Note
  5. Intel Stock Pays Out $92 Bil – Investors Take Note
  6. Comcast Stock Capital Return Hits $44 Bil

  • FFIV gained 70% in a year after showing a 6.9% free cash flow yield
  • CSCO had 6.6% yield, and returned 50% in the next 12 months
  • PM rose over 85% percent as the market noticed its 5.7% free cash flow yield and good underlying growth

But Consider Risk

That said, NVS isn’t immune to big drops. It fell about 43%-44% in both the Dot-Com Bubble and the Global Financial Crisis. More recent hits like the Covid pandemic and the 2018 correction still knocked it down 23-29%. Even the inflation shock caused a 20% dip. Solid fundamentals matter, but when the market sells off hard, NVS can take a sizable hit too.

Picking winners on a consistent basis is not an easy task – especially given the volatility associated with a single stock. Instead, the Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.